Sitemap

[pagelist exclude=“349,367,4812,4745,4710,2014,4656″]

Nachrichten

Bavarian Award ‘m4’ honours the TherVacB innovative therapeutic vaccine as a promising solution to the global health challenge of chronic hepatitis B

Bavarian Award ‘m4’ honours the TherVacB innovative therapeutic vaccine as a promising solution to the global health challenge of chronic hepatitis B

Professor Ulrike Protzer and her TherVacB team at Helmholtz Munich and TUM have been honoured with the prestigious Bavarian m4 Award 2023. Key members of the Helmholtz Munich and TUM team for TherVacB proudly received the m4 Award on 24 October 2023 at Munich...

TherVacB